Dongli Hu Selected Research

palbociclib

12/2021

KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongli Hu Research Topics

Disease

5	Neoplasms (Cancer) 03/2024 - 06/2015
5	Neuroblastoma 03/2024 - 06/2015
1	Wilms Tumor (Wilm's Tumor) 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 06/2021
1	Carcinogenesis 06/2015

Drug/Important Bio-Agent (IBA)

3	Histone DemethylasesIBA 12/2021 - 06/2015
2	CarbonIBA 03/2024 - 11/2023
2	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 03/2024 - 11/2023
2	RNA Splicing FactorsIBA 03/2024 - 11/2023
2	Arginine (L-Arginine)FDA Link 03/2024 - 11/2023
2	EnzymesIBA 03/2024 - 11/2023
2	GlutaminaseIBA 03/2024 - 11/2023
2	Glutamine (L-Glutamine)FDA Link 03/2024 - 11/2023
2	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 03/2024 - 11/2023
2	RNA Precursors (Precursor, mRNA)IBA 03/2024 - 11/2023
2	Protein Isoforms (Isoforms)IBA 03/2024 - 11/2023
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	palbociclibIBA 12/2021
1	LipidsIBA 06/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2021
1	Ciclopirox (Loprox)FDA LinkGeneric 01/2017
1	Small Interfering RNA (siRNA)IBA 06/2015
1	Histones (Histone)IBA 06/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2021
1	Therapeutics 01/2017